Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06419777 · ClinicalTrials.gov registry record · NA

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

A NA study of Pregnancy Related and Gestational Diabetes, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
430
Enrollment target
2
Study locations

NCT06419777 is a NA study of Pregnancy Related and Gestational Diabetes that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 430 participants, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06419777, a NA study of Pregnancy Related and Gestational Diabetes, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
430 participants
Enrollment target
2
Study locations

Study Summary

The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a strict and permissive threshold. The strict threshold is defined as two abnormal values or more over a one-week period (two fasting values elevated, two of the same post prandial values elevated, or 1 fasting and 1 post prandial value elevated), whereas the permissive threshold is defined as 50% of values elevated over 1 week (50% of overall fasting values, 50% of postprandial values, or 50% of overall values).

Interventions

  • DRUG Insulin

Study Locations (2)

New York

  • University of Rochester Medical Center - Rochester

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2024-09-01
Est. Completion 2026-05
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT06419777

The ClinicalTrials.gov registry entry for NCT06419777 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,959-participant average among 99 other Pregnancy Related trials with a reported enrollment target (78% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Insulin is the first listed.

NCT06419777 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06419777 about?

NCT06419777 is a clinical study titled "Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes". The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a strict and permissive threshold. The strict threshold is defined as two abnormal values or more ov...

What is the current status of trial NCT06419777?

This trial is currently recruiting. It is a NA study. The enrollment target is 430 participants. The study started on 2024-09-01. Estimated completion is 2026-05.

What conditions does trial NCT06419777 study?

This clinical trial studies the following conditions: Pregnancy Related, Gestational Diabetes.

What interventions are being tested in trial NCT06419777?

The interventions under investigation include: Insulin (DRUG).

Who is sponsoring clinical trial NCT06419777?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06419777 being conducted?

This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.